Aimei Health Technology income statement data for the quarter ended Dec 2025. This income statement covers 9 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||
| Other Operating ExpensesOther Opex | 0.15M | 0.31M | 0.20M | 0.40M | 0.41M | 0.04M | 0.13M | ||
| Operating ExpensesOpex | 0.15M | 0.31M | 0.20M | 0.40M | 0.41M | 0.04M | 0.13M | ||
| Operating IncomeOp. Inc | -0.15M | -0.31M | -0.20M | -0.40M | -0.41M | -0.04M | -0.13M | ||
| EBIT | -0.15M | -0.31M | -0.20M | -0.40M | -0.41M | -0.04M | -0.13M | ||
| Non-operating items | |||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.91M | 0.92M | 0.94M | 0.85M | 0.60M | 0.47M | 0.48M | ||
| Non Operating IncomeNon Op. Inc. | 0.91M | 0.92M | 0.94M | 0.85M | 0.60M | 0.47M | 0.48M | ||
| Net income details | |||||||||
| EBT | -0.15M | -0.31M | -0.20M | -0.40M | -0.41M | -0.04M | -0.13M | ||
| Profit After TaxPAT | 0.76M | 0.61M | 0.74M | 0.44M | 0.18M | 0.42M | 0.35M | ||
| Income from Continuing OperationsIncome (Continuing) | -0.15M | -0.31M | -0.20M | -0.40M | -0.41M | -0.04M | -0.13M | ||
| Consolidated Net IncomeConsol Net Inc. | -0.15M | -0.31M | -0.20M | -0.40M | -0.41M | -0.04M | -0.13M | ||
| Income towards Parent CompanyParent Net Inc | -0.15M | -0.31M | -0.20M | -0.40M | -0.41M | -0.04M | -0.13M | ||
| Net Income towards Common StockholdersNet Income | -0.15M | -0.31M | -0.20M | -0.40M | -0.41M | -0.04M | -0.13M | ||
| Additional items | |||||||||
| EPS (Basic) | -0.01 | -0.02 | -0.01 | -0.02 | -0.08 | 0.00 | -0.03 | ||
| EPS (Diluted) | -0.01 | -0.02 | -0.01 | -0.02 | -0.03 | 0.00 | -0.03 | ||
| Shares Outstanding | 2.23M | 18.05M | 18.05M | 18.05M | 18.05M | 5.16M | 12.24M | 4.00M | 4.05M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 2.23M | 18.05M | 18.05M | 18.05M | 18.05M | 14.57M | 12.24M | 4.00M | 12.35M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 2.13M | 18.05M | 18.05M | 18.05M | 18.05M | 5.16M | 12.24M | 4.00M | 4.05M |
| EBITDA | -0.15M | -0.31M | -0.20M | -0.40M | -0.41M | -0.04M | -0.13M |